Release Date: December 28, 2017
Expiration Date: December 28, 2018
Media: Internet - based
Atopic dermatitis (AD) is a multifactorial, multisystem disease, and interactions among biologic, genetic, environmental, and behavioral factors affect the course of the disease. Research suggests that the multidisciplinary care of people with AD may improve disease severity, quality of life, and adherence, especially for patients with refractory disease. This program reviews the importance of approaching this multisystem disease with multidisciplinary care that incorporates novel therapies, lifestyle measures, patient education, and patient-clinician shared decision-making.
Instructions for This Activity and Receiving Credit
Dermatologists, Allergists, Immunologists, Rheumatologists, and Primary Care Physicians
At the completion of this activity, the participant will be able to:
The staff of PER® have no relevant financial relationships with commercial interests to disclose.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physician’s Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource, LLC®. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour, which includes 0 hour(s) of pharmacology.
Activity ID # 2414E
This activity was planned in accordance with AANP CE Standards and Policies.
For information about the approval of this program, please contact Global at 303-395-1782 or email@example.com.
To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online posttest and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit by December 29, 2018; CE credit will not be issued after this date.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Physicians’ Education Resource, LLC® (PER®) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019